PL3551624T3 - Podstawiona pochodna benzimidazolu jako modulator aktywności tnf - Google Patents
Podstawiona pochodna benzimidazolu jako modulator aktywności tnfInfo
- Publication number
- PL3551624T3 PL3551624T3 PL17811318T PL17811318T PL3551624T3 PL 3551624 T3 PL3551624 T3 PL 3551624T3 PL 17811318 T PL17811318 T PL 17811318T PL 17811318 T PL17811318 T PL 17811318T PL 3551624 T3 PL3551624 T3 PL 3551624T3
- Authority
- PL
- Poland
- Prior art keywords
- modulator
- benzimidazole derivative
- substituted benzimidazole
- tnf activity
- tnf
- Prior art date
Links
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1620948.8A GB201620948D0 (en) | 2016-12-09 | 2016-12-09 | Therapeutic agents |
| PCT/EP2017/082092 WO2018104534A1 (en) | 2016-12-09 | 2017-12-08 | A substituted benzimidazole derivative as a modulator of tnf activity |
| EP17811318.9A EP3551624B1 (en) | 2016-12-09 | 2017-12-08 | A substituted benzimidazole derivative as a modulator of tnf activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3551624T3 true PL3551624T3 (pl) | 2021-07-05 |
Family
ID=58222106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17811318T PL3551624T3 (pl) | 2016-12-09 | 2017-12-08 | Podstawiona pochodna benzimidazolu jako modulator aktywności tnf |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10669263B2 (pl) |
| EP (1) | EP3551624B1 (pl) |
| JP (1) | JP6983238B2 (pl) |
| KR (1) | KR20190091328A (pl) |
| CN (1) | CN110023300B (pl) |
| AU (1) | AU2017371443B2 (pl) |
| BR (1) | BR112019008766A2 (pl) |
| CA (1) | CA3041081A1 (pl) |
| CL (1) | CL2019001511A1 (pl) |
| CO (1) | CO2019007115A2 (pl) |
| CY (1) | CY1124158T1 (pl) |
| DK (1) | DK3551624T3 (pl) |
| EA (1) | EA037199B1 (pl) |
| ES (1) | ES2853981T3 (pl) |
| GB (1) | GB201620948D0 (pl) |
| HR (1) | HRP20210405T1 (pl) |
| HU (1) | HUE054184T2 (pl) |
| IL (1) | IL266874B (pl) |
| LT (1) | LT3551624T (pl) |
| MX (1) | MX389379B (pl) |
| PL (1) | PL3551624T3 (pl) |
| PT (1) | PT3551624T (pl) |
| RU (1) | RU2019120527A (pl) |
| SG (1) | SG11201903655VA (pl) |
| SI (1) | SI3551624T1 (pl) |
| WO (1) | WO2018104534A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001060362A1 (fr) * | 2000-02-18 | 2001-08-23 | Takeda Chemical Industries, Ltd. | INHIBITEURS DE TNF-$g(a) |
| AU2007230911A1 (en) * | 2006-03-23 | 2007-10-04 | Synta Pharmaceuticals Corp. | Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
| BR112014030940B1 (pt) * | 2012-06-11 | 2022-09-06 | UCB Biopharma SRL | Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos |
| PE20170693A1 (es) | 2014-10-03 | 2017-06-13 | Ucb Biopharma Sprl | Derivados de imidazol pentaciclicos fusionados |
-
2016
- 2016-12-09 GB GBGB1620948.8A patent/GB201620948D0/en not_active Ceased
-
2017
- 2017-12-08 AU AU2017371443A patent/AU2017371443B2/en not_active Ceased
- 2017-12-08 BR BR112019008766A patent/BR112019008766A2/pt not_active IP Right Cessation
- 2017-12-08 KR KR1020197019326A patent/KR20190091328A/ko not_active Ceased
- 2017-12-08 CN CN201780073716.6A patent/CN110023300B/zh not_active Expired - Fee Related
- 2017-12-08 DK DK17811318.9T patent/DK3551624T3/da active
- 2017-12-08 HR HRP20210405TT patent/HRP20210405T1/hr unknown
- 2017-12-08 SG SG11201903655VA patent/SG11201903655VA/en unknown
- 2017-12-08 WO PCT/EP2017/082092 patent/WO2018104534A1/en not_active Ceased
- 2017-12-08 LT LTEP17811318.9T patent/LT3551624T/lt unknown
- 2017-12-08 US US16/349,734 patent/US10669263B2/en not_active Expired - Fee Related
- 2017-12-08 PT PT178113189T patent/PT3551624T/pt unknown
- 2017-12-08 PL PL17811318T patent/PL3551624T3/pl unknown
- 2017-12-08 RU RU2019120527A patent/RU2019120527A/ru not_active Application Discontinuation
- 2017-12-08 JP JP2019529481A patent/JP6983238B2/ja not_active Expired - Fee Related
- 2017-12-08 HU HUE17811318A patent/HUE054184T2/hu unknown
- 2017-12-08 MX MX2019006033A patent/MX389379B/es unknown
- 2017-12-08 EA EA201991294A patent/EA037199B1/ru unknown
- 2017-12-08 EP EP17811318.9A patent/EP3551624B1/en active Active
- 2017-12-08 CA CA3041081A patent/CA3041081A1/en not_active Abandoned
- 2017-12-08 ES ES17811318T patent/ES2853981T3/es active Active
- 2017-12-08 SI SI201730672T patent/SI3551624T1/sl unknown
-
2019
- 2019-05-26 IL IL266874A patent/IL266874B/en unknown
- 2019-06-04 CL CL2019001511A patent/CL2019001511A1/es unknown
- 2019-07-02 CO CONC2019/0007115A patent/CO2019007115A2/es unknown
-
2021
- 2021-03-22 CY CY20211100245T patent/CY1124158T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201705060B (en) | Use of picolinamides as fungicides | |
| RS67122B1 (sr) | Derivat pirazina kao inhibitor chk1 | |
| EP4218790C0 (en) | MODULATORS OF COMPLEMENT ACTIVITY | |
| SMT201900082T1 (it) | Tiazoli come modulatori di roryt | |
| HUE056322T2 (hu) | Benzimidazol-származék alkalmazásai éjszakai savvisszaáramláshoz | |
| GB201706571D0 (en) | Active waterway stabilizer | |
| SG11201701378WA (en) | Pyrido-oxazinone derivatives as tnap inhibitors | |
| SG11201704664VA (en) | Hydraulic lockdown | |
| GB201404697D0 (en) | Attachment of hoof blocks | |
| ZA201807559B (en) | Novel prostaglandin derivative | |
| PL2993360T3 (pl) | Układ hydrauliczny | |
| SG11201700705QA (en) | Equipment for applying active elements to the skull of a patient | |
| GB201517564D0 (en) | Pulse modulator | |
| IL266874B (en) | Consequences of benzimidazole being transformed as a modulator of TNF activity | |
| IL251099A0 (en) | A salt of phenylglycine methyl ester | |
| PL3150065T3 (pl) | Opryskiwacz zawieszany do ciągnika | |
| PT3165222T (pt) | Utilização do composto de ftalida | |
| TH1501004530A (th) | ฟลูอิดไดซ์เบดแก๊สซิไฟเออร์ | |
| SG11201605485QA (en) | Synthesis method of 9-allylcamptothecin derivatives | |
| TWM490349U (en) | Improved structure of a darter | |
| GB201421628D0 (en) | Ratak hydraulic system | |
| BR302014002200S1 (pt) | Configuração aplicada em equipamento odontológico | |
| TWM476648U (en) | Improved structure of electric agricultural sprayer |